Impact of glucocorticoids on the incidence of lupus-related major organ damage: a systematic literature review and meta-regression analysis of longitudinal observational studies.
Manuel Francisco Ugarte-GilAnselm MakJoanna LeongBhushan DharmadhikariNien Yee KowCristina Reatégui-SokolovaClaudia Elera-FitzcarraldCinthia AranowLaurent ArnaudAnca D AskanaseSang-Cheol BaeSasha BernatskyIan N BruceJill BuyonNathalie Costedoat-ChalumeauMary Ann DooleyPaul R FortinEllen M GinzlerDafna D GladmanJohn HanlyMurat InancDavid IsenbergSoren JacobsenJudith A JamesAndreas JönsenKenneth KalunianDiane L KamenSung Sam LimEric F MorandMarta MoscaChristine PeschkenBernardo A Pons-EstelAnisur RahmanRosalind Ramsey-GoldmanJohn ReynoldsJuanita Romero-DiazGuillermo Ruiz-IrastorzaJorge Sánchez-GuerreroElisabet SvenungssonMurray B UrowitzEvelyne VinetRonald F Van VollenhovenAlexandre VoskuylDaniel J WallaceMichelle A PetriSusan ManziAnn Elaine ClarkeMike CheungVernon FarewellGraciela S AlarconPublished in: Lupus science & medicine (2022)
We confirm associations of GC use with three specific damage items. In treating patients with SLE, our aim should be to maximise the efficacy of GC and to minimise their harms.